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a high throughput imaging 
database of toxicological effects of 
nanomaterials tested on HepaRG 
cells
Elisabeth Joossens1, Peter Macko1, taina Palosaari1, Kirsten Gerloff1, Isaac Ojea-Jiménez1, 
Douglas Gilliland1, Jaroslav Novak1, Salvador Fortaner torrent1, Jean-Michel Gineste1, 
Isabella Römer2,3, Sophie Marie Briffa2, Eugenia Valsami-Jones  2, Iseult Lynch  2 & 
Maurice Whelan1
the large amount of existing nanomaterials demands rapid and reliable methods for testing their 
potential toxicological effect on human health, preferably by means of relevant in vitro techniques 
in order to reduce testing on animals. Combining high throughput workflows with automated high 
content imaging techniques allows deriving much more information from cell-based assays than the 
typical readouts (i.e. one measurement per well) with optical plate-readers. We present here a dataset 
including data based on a maximum of 14 different read outs (including viable cell count, cell membrane 
permeability, apoptotic cell death, mitochondrial membrane potential and steatosis) of the human 
hepatoma HepaRG cell line treated with a large set of nanomaterials, coatings and supernatants at 
different concentrations. The database, given its size, can be utilized in the development of in silico 
hazard assessment and prediction tools or can be combined with toxicity results from other in vitro test 
systems.
Background & Summary
The increasing use of manufactured nanomaterials (MNMs) in food, industrial processes and consumer products 
poses a significant challenge to industry and regulatory bodies with regard to demonstrating their safety1–4. Issues 
being faced include the often peculiar properties exhibited by MNMs which can lead to unpredictable behaviour 
in biological systems and the growing pressure to move away from traditional animal tests used for toxicological 
hazard assessment due both to ethical and scientific reasons. There is strong interest therefore to pursue the devel-
opment and application of in vitro and in silico methods which have the potential to progressively replace animal 
testing for the generation of toxicological data that can support the safety assessment of MNMs in a variety of 
contexts5.
The combination of in vitro High Throughput Screening (HTS) and High Content Imaging (HCI) delivers 
rapid and reliable toxicity assessment of large numbers of MNMs in parallel and can combine several endpoint 
measurements in one experiment6. In this context, the use of automated robotic platforms is extremely useful 
since it ensures a high degree of technical reproducibility within and between experiments and keeps potential 
operator-induced bias to a minimum.
The overall goal of this HTS-HCI study was to provide a large set of high quality in vitro toxicity data for the 
purpose of an initial hazard-based ranking of MNMs in order to identify candidates for subsequent more detailed 
toxicological assessment. An additional aim was to use the dataset to explore the development of MNM-specific 
Quantitative Property Activity Relationships (QPARs) by combining the toxicity data with the physiochemical 
properties of the MNMs. To our knowledge, this database is the largest of its kind that covers such a wide selec-
tion of MNMs.
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The creation of the database was initiated as part of the European Union funded project NanoMILE7, with 
resulting Knowledge Base8. Within the project a 3-tiered approach was adopted in which a preliminary series of 
MNMs was sourced from commercial suppliers and existing libraries such as the JRC nanomaterials repository 
(Batch 1). In parallel with this a second tier of in-house synthesised MNMs with known or predictable properties 
were prepared (Batch 2). Finally, as the project progressed and new needs were identified a third tier (Batch 3) of 
novel or highly tailored MNMs was developed on request to tackle specific problems or to test hypothesis identi-
fied during the testing of the first two batches9.
The MNMs were tested on the human hepatoma cell line, HepaRG. These cells show hepatocyte-like functions 
and express drug detoxifying enzymes at near in vivo levels10. This cell line has also been demonstrated to be suit-
able for use in HTS and HCI assays with chemicals11.
A total of 89 MNMs were tested which had different composition, size and surface properties, there were also 
present 3 coatings, 4 supernatants and 7 solvents/diluents. In all, 14 imaging endpoints were measured in the 15 
experiments conducted. MNMs were tested at 10 different concentrations in 3 independent experiments (biologi-
cal replicates). Four MNMs were tested in only two biological replicate-experiments because of their late delivery. 
Two other MNMs (PS-NH2 50 nm and PS-COOH 100 nm) have no biological replicates.
A schematic overview of the experiments is provided in Fig. 1. The main type of experiment (type 1) addressed 
mitochondrial health and cell viability and was performed on all MNMs. This combined three different fluores-
cent dyes to analyse the nuclei, the state of the cell membrane (cell membrane damage), and the mitochondrial 
membrane potential. The HCI allows for a population analysis dividing the cell population into subpopulations 
with different characteristics defining the health of cells. For Batch 1, two additional types of experiments were 
performed, namely, detection of steatosis based on the detection of intracellular accumulation of neutral lipids 
(type 2), and measurement of apoptosis (type 3). All experiments included an analysis of cell nuclei.
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Fig. 1 Graphical overview of the experiments performed.
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Methods
cell lines. The HepaRG human hepatic cell line was established by the INSERM (National Institute of Health 
and Medical Research) laboratory at Rennes, France. For this study, undifferentiated HepaRG cells were pro-
vided by Biopredic International (Rennes, France) in cryopreserved vials. The cells were maintained in culture 
medium consisting of William’s MediumE (Thermo Fisher Scientific, Melegnano, Italy) with 10% FBS (HyClone 
Fetal- Clone III, HyClone), 1% l-glutamine, 1% penicillin/streptomycin, 5 μg/ml bovine insulin and 50 μM hydro-
cortisone (all from Sigma, Milan, Italy). The cells were seeded at a density of 1 × 106 cells into 75 cm2 flasks and 
the medium was refreshed every 2 to 3 days. Upon reaching confluence, the cells were transferred into 150 cm2 
flasks. After 14 days, the cells start to differentiate into hepatocyte- and biliary-like cells. This process is supported 
by changing to differentiation medium, which consists of maintenance medium plus 1.7% DMSO (starting with 
0.85% DMSO for 1 day). After 2 weeks in differentiation medium, the hepatocytes were selectively trypsinised and 
detached whereas the biliary cells remained adhered to the plate. The hepatocytes were then transferred into clear 
bottom black polystyrene 96-well microplates (5 × 104 cells/well in 100 μL) by an automated procedure.
Nanomaterials and chemical controls. As described above, 3 separate batches of test items were tested in 
a series of 15 HTS-HCI experiments. The Batch 1 contained 26 test items, consisting of 25 MNMs and 1 diluent. 
The Batch 2 contained 51 test items, of which 50 were mainly ultra-small MNMs and 1 was a supernatant. The 
Batch 3 contained 28 test items, consisting of 16 MNMs, 3 coating materials, 3 supernatants and 6 diluents. A 
reference MNM (PS-NH2) was included in all batches. Each of the experiments also contained HepaRG samples 
treated with chemical compounds with known effect which were used as controls to assess the performance of 
the robotic platform and of the staining. Type 1 experiments for mitochondrial health and cell viability contained 
Valinomycin and Cadmium Chloride. Type 2 experiments for steatosis contained CyclosporineA and type 3 
experiments for apoptosis (Caspase 3) contained Cyclohexamide.
Overall the database includes data on 29 cerium dioxides, 17 silica, 12 titanium dioxides, 8 zinc oxides, 8 silver, 5 
gold, 3 polystyrene, 3 calcium, 2 copper oxide, 1 barium, and 1 iron oxide MNMs with different sizes and coatings.
The reference MNM, PS-NH2, was selected for its known chemical and physical properties and behaviour in 
vivo12,13. A detailed discussion on the sequence of events leading to PS-NH2-induced death of astrocytoma cells 
can be found in the literature13. The sequence is as follows: increase of lysosomal volume – increased ROS levels 
– loss of lysosomal integrity – shrinkage of cell size – loss of mitochondrial membrane potential – loss of plasma 
membrane integrity – cell death. The impairment of mitochondria marks the point of no return for cell death. It 
has further been shown that the biomolecular corona of the PS-NH2 nanomaterial is retained during the uptake 
into the cell until they reach the lysosomes where the corona is degraded14, more specifically it was reported on 
different tested cell lines (HEK293, HepG2, hCMEC/D3, A549, SHSY5Y, 1321N1, RAW264.7)15.
The negative controls used were cells treated with medium. Additionally, cells were tested when exposed to 
water during the experimental design phase but no observable influence was detected. Within the experiment, the 
different diluents used for the MNMs were tested and are included in the DB.
In-depth characterisation of the tested MNMs was performed within the NanoMILE project and results are 
included in the excel sheet MNM characterisation which is part of the investigation file. Some additional charac-
terisation of certain MNMs was carried out in other contexts, including for the functionalized SiO2 MNMs16. For 
the JRC TiO2 materials NM-103 and NM-104 the physico-chemical characterisation data are available on the JRC 
Nanomaterials Repository17 and are included in the report18. In the field of nano-bioscience, reporting standards 
have been developed to enhance the quality and reuse of published research19. As proposed therein, we provide 
information on size, shape, aggregation, zeta potential and density (mass/volume) of the majority of materials 
within the associated Metadata Record. Hence, if required for example, one could apply mathematical models20 
to estimate the actual cellular dose.
Common protocols for particle dispersion and cell exposure, developed within the NanoMILE project, were 
used for all MNMs21. A summary of these dispersion protocols is included also in the JRC data catalogue22 and 
the characterisation file contains specific information of the applied protocol per MNM.
It is to be noted that all dispersions concerning ion releasing particles were always prepared at the end of 
each batch and immediately exposed to the cells in order to reduce the amount of free ions at the outset of the 
exposure. In general, the time between MNM dispersion and exposure varied from 30 to maximum 60 minutes.
cell treatment and staining. All the procedures for cell seeding, serial dilution of test items, cell treat-
ment and cell staining were fully automated on Hamilton Star and Starlet platforms (Hamilton Italia Srl, Agrate 
Brianza, Italy). These robotic liquid handlers are equipped with 96-tip heads and installed either in a laminar 
hood (cell seeding, serial dilution of test items, cell treatment) or in a chemical fume hood (cell staining).
Plates were treated following a ‘quantitative HTS’ (qHTS) format, where all plates had the same plate layout 
and every plate corresponded to one tested concentration23. Thus for each experiment, 10 seeded 96-well-plates 
were used for the 10 concentrations tested. The highest particle concentration used was 250 μg/ml; followed by, 
plate by plate, serial 1:2 dilutions, the lowest concentration being 0.49 μg/ml (see Fig. 2).
For the experiments all 96 wells of the plates were used. The plate layout slightly changed from one experiment 
to another but followed a general concept. Namely, in addition to the tested items, each plate contained at least 
four negative control wells where cells were treated only with medium, and a number of wells with chemical 
controls. When possible, each plate contained two technical replicates of the tested items. For Batch 1 and Batch 
3, all the tested items were present in duplicates on the plate but for the Batch 2 the size of the plate did not allow 
accommodating all 51 tested items in duplicates on a plate. Therefore, on each experiment the plate layout was 
modified in such a way that for every tested item two technical replicates were available in at least one of the three 
repeated experiments, i.e. biological replicates (see Fig. 3).
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Cells were exposed to the test items for duration of 24 hours after which the cells were stained according to the 
experiment performed.
The main type 1 experiment (mitochondrial health and cell viability), was performed on all tested items and 
combined three different fluorescent dyes to analyse the nucleus (Hoechst 33342), the state of the cell membrane 
(cell membrane damage, Image-iT® DEAD Green viability stain), and the mitochondrial membrane poten-
tial (MitoHealth stain). These dyes are included in the HCS Mitochondrial Health Kit, Invitrogen Catalog no. 
H10295.
The type 2 experiment contained in addition to the nucleus staining dye (Hoechst 33342), also a dye for intra-
cellular accumulation of neutral lipids (HCS LipidTOX™ Green Neutral Lipid Stain, Thermofisher Catalog no. 
H34475) and the type 3 experiment contained a dye for the detection of apoptosis (immunofluorescent staining 
using as primary antibody Anti-ACTIVE® Caspase-3 pAb, Promega Catalog no. G7481 and secondary antibody 
AlexaFluor 488 Goat anti-Rabbit IgG, catalog no. Abcam Ab150077).
The staining was performed on a separate Hamilton Starlet platform under a chemical safety hood dedicated 
to this purpose. Staining procedures applied are those provided by the kit producer. All the steps during staining 
were fully automated; the washing steps were performed by an incorporated automated washer with a 96-needle 
head for aspiration and for addition of wash solutions (typically PBS). The plates were processed in the same order 
as they were exposed to the nanomaterials (from C10, lowest concentration, to C1, highest concentration) and 
in case of need for medium removal, this was done using the robot’s 96-pipette head. More details on the pro-
cesses and the preparation of solutions can be found in DB-ALM Method summary 167 (https://ecvam-dbalm.
jrc.ec.europa.eu/).
Plate 1
Conc. 1
Plate 2
Conc. 2
Plate n
Conc. n
1:2
Fig. 2 Graphical overview of the qHTS layout.
1 2 3 4 5 6 7 8 9 10 11 12
A  CdCl2 Dil ITEM1 ITEM8 ITEM16 ITEM24 ITEM32 ITEM40 ITEM46 Valin Dil ITEM13 Valin Fix ITEM25
B CdCl2 Dil PS-NH2 ITEM9 ITEM17 ITEM25 ITEM33 ITEM41 ITEM47 Valin Dil ITEM14 Valin Fix ITEM26
C CdCl2 Dil ITEM2 ITEM10 ITEM18 ITEM26 ITEM34 medium ITEM48 Valin Dil ITEM15 Valin Fix ITEM27
D NC ITEM3 ITEM11 ITEM19 ITEM27 ITEM35 medium ITEM49 Valin Dil ITEM16 Valin Fix ITEM28
E NC ITEM4 ITEM12 ITEM20 ITEM28 ITEM36 ITEM42 ITEM50 NC ITEM17 ITEM21 ITEM29
F CdCl2 Fix ITEM5 ITEM13 ITEM21 ITEM29 ITEM37 ITEM43 ITEM51 NC ITEM18 ITEM22 ITEM30
G CdCl2 Fix ITEM6 ITEM14 ITEM22 ITEM30 ITEM38 ITEM44 medium PS-NH2 ITEM19 ITEM23 ITEM31
H CdCl2 Fix ITEM7 ITEM15 ITEM23 ITEM31 ITEM39 ITEM45 medium ITEM12 ITEM20 ITEM24 ITEM32
Fig. 3 Example of the plate layout of run 2 of the type 1 experiment for the Batch 2 items (experiment 11). Here 
only ITEM12 to ITEM32 have technical replicates on the plate. For runs 1 and 3 (i.e. biological replicates) of 
the same type 1 experiment, the wells in columns 9 to 12 were treated with other ITEMS to have at least one 
technical replicate per ITEM. CaCl2 and Valinomycin were added as reference chemicals and are both diluted 
from starting concentrations of 11 μM and 165 nM respectively; i.e. are diluted following the 1:2 scheme like the 
MNMs or added manually at a fixed concentration on each plate.
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automated cell image acquisition and data production. To acquire and analyse the fluorescence 
images of stained cells in the 96-well plates a Cellomics ArrayScan® VTI high content imaging instrument 
(Thermo Scientific) was used. This instrument is designed for high-capacity automated fluorescence imaging 
and quantitative analysis of fixed and living cells. It is composed of an inverted fluorescence microscope Zeiss™ 
Axio Z1 Observer from Carl Zeiss, a hotel which accommodates up to 45 standard 96-well-plates and a Catalyst 
Express robotic arm that feeds plates from the hotel into the microscope stage and back. The fluorescence micro-
scope is equipped with motor driven stage, objective changer, autofocus system, and filter-wheel with different 
sets of filters and dichroic mirrors for fluorescence channel selection. The excitation light is delivered from a high 
intensity mercury vapour arc light source through a waveguide and the fluorescence images are recorded by a 
high sensitivity CCD camera.
The plate handling workflow is controlled with the scheduling software Polara and the image acquisition, anal-
ysis, visualisation, and storage with the HCS Studio™ Cell Analysis software (Thermo Scientific™ HCS Studio™ 
2.0 Cell Analysis Software, Thermofisher Catalog no.: SX000041A). The HCS Studio™ Cell Analysis software is 
used for creating and modifying Assay Protocols. In Assay Protocols, users configure the acquisition parameters 
(e.g. objective, image resolution, number of fluorescence channels and their excitation/emission wavelengths, 
exposure times, number and position of images per well and wells per plate to be scanned), the assay param-
eters (type of image processing, object identification, selection, validation and analysis), and the cell and well 
features to be stored. The image analysis can be done either on-the-fly or after the acquisition. In this study the 
image acquisition and analysis were done separately as the on-the-fly approach slowed down the acquisition and 
sometimes overloaded the control computer due to the highly demanding calculations for image analysis. This 
approach was also used to iteratively reanalyse acquired images which was particularly useful for classification 
of the cells into the subpopulations; all properties are summarized in Online-only Table 1. The thresholds for cell 
classification were set based on cellular features calculated in the first image analysis, and subsequently applied 
in the second image analysis. To configure the Assays Protocols two Bioapplications were used; Compartmental 
Analysis.v.4 for type 1 and type 2 experiments and Colocalisation.v.4 for type 3 experiment. The objective 20x 
was used and 10 connected images in the middle of each well were recorded. The images from all experiments 
(432,000 images from 15 experiments * 96 wells * 10 concentrations * 10 fields_of_view * 3 channels) are stored 
and can be provided upon request via the JRC data catalogue22.
In all three types of experiments the cellular nuclei were stained with the Hoechst 33342 dye and imaged in the 
channel 1. This stain provided a marker for the cell identification and their total counts ‘Valid Object Count’, the 
average ‘Nuclear size’ and the average ‘Nuclear Intensity’ were calculated across all the cells in a well and stored 
in the database.
In the type 1 experiment, the ImageDeadGreen dye stained the cells which had cell membrane damage and 
these were imaged in channel 2. The average pixel intensity of this stain in the area of nucleus for each identified 
cell was calculated and averaged across all the cells in a well and then used as an indicator of the ‘Cell Membrane 
Damage’. In channel 3 the MitoHealth dye which stained the cytoplasmatic mitochondria was imaged and then 
used as an indicator of its mitochondrial membrane potential. The cytoplasm was defined as a ring of a prede-
fined size around the selected nuclei and the average pixel intensity was calculated and averaged across all the 
cells in a well and then used as an indicator of the ‘Reduced Mitochondrial Potential’. Additionally, the cells were 
categorised into four phenotypic sub-populations. The combination of two selection criteria was used: normal 
or reduced mitochondrial potential, and normal or damaged cell membrane. The portion of the cells in three 
of these four phenotypic sub-populations are in the database: ‘Attached cells without reduced mitochondrial 
potential and no cell membrane damage’, ‘Attached cells with reduced mitochondrial potential but without cell 
membrane damage’, and ‘Attached cells with normal mitochondrial potential but with cell membrane damage’ 
whereas the fourth sub-populations can be calculated as what remains to arrive at 100%.
In the type 2 experiment, the steatotic cells were identified by imaging the accumulated lipid droplets in their 
cytosol which were stained with the HCS LipidTOX™ Green Neutral Lipid Stains. The total area of the lipid drop-
lets in each cell was calculated and then averaged across all the cells in a well and used as the marker for steatosis 
‘Lipid Droplet’.
In the type 3 experiment, the apoptotic cells were identified by using the immunostaining Anti-ACTIVE® 
Caspase-3 pAb - AlexaFluor 488 Goat anti-Rabbit IgG. In each cell the presence of this stain for cleaved 
Caspase-3 was quantified separately in the nucleus and cytosols. The cells were then categorised into three phe-
notypic sub-populations, having either no Caspase-3 ‘Caspase Negative Cells’, Caspase-3 only in the cytoplasm 
‘Cytoplasmic Caspase’ for detection early apoptosis, or in the nucleus or both the cytosol and the nucleus ‘Nuclear 
Caspase’ for late apoptosis. On top of that the overall mean Caspase-3 staining ‘Total Caspase’ was calculated over 
all cells in a well.
Normalization of the data. The raw data files per plate were loaded into Excel and merged to produce 
a single data file per experiment. As a first step, the data were analysed experiment by experiment following 
the signal-to-noise ratio approach24,25. The following steps were followed separately for every feature (endpoint) 
within one experiment:
•	 Step 1: On each of the plates (labelled by subscript i) the average response of the 4 negative controls was calcu-
lated for each feature (µci−), to obtain the average plate behaviour without MNM influence.
•	 Step 2: The difference between a negative control signal and the average negative control signal was defined as 
noise. So, for each plate, 4 noise values were obtained by subtracting the individual negative control responses 
from their plate average.
•	 Step 3: The noise data from the separate plates was put together to get, and aggregated to an overall standard 
deviation of the noise signal for the experiment (σnoise). It was obtained using the 4 ‘noise signals’ per plate 
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from all plates, so a total of 40 noise signals were used to calculate an overall standard deviation. This ensured 
that the overall standard deviation was calculated from a large enough set of data. The negative control signal 
on each plate and the overall standard deviation were used to normalize the data for each of the test items on 
the plate. This measure of standard deviation is used to quantify the amount of variation or dispersion of a 
set of data values.
•	 Step 4: If available, two technical replicates of the feature for each concentration were averaged for each tested 
item, otherwise the individual value for the item concentration was used (µxi).
•	 Step 5: The plate average negative response (step 1) was subtracted from the average item signal (step 4). This 
way a pure item response was obtained as any potential plate-specific effects were removed.
•	 Step 6: The difference from step 5 was then compared to the overall noise signal by dividing:
= μ −μ σ−z ( )/xi xi ci noise
For each item-feature combination within an experiment, using the information of all 10 plates, a dose 
response curve was obtained using the signal-to-noise data.
This normalization allows comparing data from different features and experiments on one plot and immedi-
ately provides an idea if the effect induced by a test item is of significance using, for example, a threshold of −3 
(downwards response) or 3 (upwards response) which corresponds to a 99% certainty that the cell behaviour is 
different from the control value under the assumption that the difference between the two signals is normally 
distributed.
The feature results of the same item tested at a certain concentration can also be combined across experiments 
by averaging zxi. For the creation of the presented database every item-feature combination was tested for all 
concentrations in three independent experiments. The average of three different experiments is presented in the 
database. As is the case for a single experiment, assessment of the significance of the signal can be done by com-
paring the average of the three experiments to the thresholds −3/√3 and 3/√3 (with 99% certainty).
Data Records
All data is available at the JRC data catalogue22. A general Excel file named ‘Investigation’ contains an overview 
of the individual experiments, the name of files with the raw data (also included as Table 1), and the metadata of 
all assays. The file is complemented by a separate sheet containing all the available characterisation data of the 
nanomaterials labelled ‘DB characterisation’. This sheet also contains the information on the dispersion protocol 
used and the availability of the nanomaterials themselves. For each experiment, the raw data files are within the 
subfolder\RawData. There is one Excel file per experiment containing plate per plate (stored on separate sheets) 
recorded data. Sheet ‘plate 1’ refers to the all relevant endpoints from the highest concentration plate while sheet 
‘plate 10’ refers to the lowest concentration plate. The plate layouts of all experiments are also included in the 
‘Investigation’ Excel file.
A subfolder\TransformedData contains files with the transformed data for each of the experiments. In each 
file the data from all plates are grouped together on one sheet per endpoint. In each of these sheets, the first set 
of columns labelled ‘Original Data’ contains the averaged raw data of the technical replicates (on plate) while the 
second set of columns labelled ‘Transformed Data’ contains the signal-to-noise transformed data per MNMs.
Averaging the transformed data across the three experiments, which represent three biological replicates, lead 
to the values recorded in the final DB for each NMMs-endpoints-concentration combination.
In addition, a subfolder\Methods contains a document with details on the three protocol versions for disper-
sion of MNMs (depending on their hydrophobicity) and the three source codes for the data acquisition.
Experiment 
number Date Type of experiment Timepoint Filename
1 13/02/2014 Steatosis 24 h Experiment1-Batch1-Steatosis.xlsx
2 17/02/2014 Caspase3 24 h Experiment2-Batch1-Caspase3.xlsx
3 24/02/2014 Steatosis 24 h Experiment3-Batch1-Steatosis.xlsx
4 27/02/2014 MH-CellViability 24 h Experiment4-Batch1-MitoHealth-CellViability.xlsx
5 27/03/2014 MH-CellViability 24 h Experiment5-Batch1-MitoHealth-CellViability.xlsx
6 24/11/2014 MH-CellViability 24 h Experiment6-Batch1-MitoHealth-CellViability.xlsx
7 27/11/2014 Steatosis 24 h Experiment7-Batch1.Steatosis.xlsx
8 01/12/2014 Caspase3 24 h Experiment8-Batch1-Caspase3.xlsx
9 15/12/2014 Caspase3 24 h Experiment9-Batch1-Caspase3.xlsx
10 03/08/2015 MH-CellViability 24 h Experiment10-Batch2-MitoHealth-CellViability.xlsx
11 30/11/2015 MH-CellViability 24 h Experiment11-Batch2-MitoHealth-CellViability.xlsx
12 14/12/2015 MH-CellViability 24 h Experiment12-Batch2-MitoHealth-CellViability.xlsx
13 13/06/2016 MH-CellViability 24 h Experiment13-Batch3-MitoHealth-CellViability.xlsx
14 20/06/2016 MH-CellViability 24 h Experiment14-Batch3-MitoHealth-CellViability.xlsx
15 27/06/2016 MH-CellViability 24 h Experiment15-Batch3-MitoHealth-CellViability.xlsx
Table 1. Experimental study raw data sources.
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Physiochemical properties of the MNMs are stored in a separate sheet from the toxicity results obtained 
within this experiment. Each MNM has a unique name and identifier so merging the sheets to querying toxicity 
data based on physiochemical properties is possible.
technical Validation
For the technical validation of the data a stepwise approach was followed. First the data within an experiment 
was validated, followed by a validation across experiments within one type of experiment. Finally, data across 
experiment types were compared.
Stability of each individual experiment. The data from all control wells of the different plates within an 
experiment were put next to each other graphically. Confirmation on the stability was checked in various ways.
It was checked if the negative controls within a plate and within the experiment were stable. An example from 
the experiment 10 is shown in the Table 2. The coefficient of variation within each plate varied from 3% to 15%. At 
the same time, the coefficient of variation obtained from all ten plate averages was less than 10%.
A similar stability check was performed on the wells with the positive control chemicals. Table 3 shows that 
the signal in the wells where the positive control chemicals where at fixed concentrations across the plates, were 
stable within an experiment. The coefficient of variation for the three added chemicals was between 6 and 14%.
Additionally, Fig. 4 demonstrates that the positive controls induced an evident effect compared to the negative 
controls, i.e. a reduction of the signal in the case of the mitochondrial membrane potential. In order to confirm 
the quality of our assay we used the z’-factor where the mean and the standard deviation of the positive controls 
within a plate were compared with the mean and the standard deviation of the negative controls. A classic HTS 
format26 normally includes a large number of positive controls per plate. For this qHTS format, with small num-
ber of controls within a plate, we used the negative and positive control signals present on all plates at a fixed 
concentration to obtain a z’-factor for the experiment. The averages within a plate were used for the calculation 
of the z’-factor which was 0.58 for Cadmium Chloride at 100 µM, thus confirming the quality of our qHTS assay 
(see Table 3).
Besides the fact that the wells treated with the chemical controls at the high concentration showed their sig-
nificant effect on the cells with respect to the negative control wells, it can also be observed that these compounds 
do show a classic Hill dose response behaviour when the compound is diluted across the plates (dilution factor 2). 
For the wells treated with the highest dose (present on plate 1) the signal is significantly different from that of the 
negative control, while for the wells where the lowest doses were applied (present on plate 10) the signal is similar 
to the negative control wells (See Fig. 4).
Verification of responses of MNMs within an experiment. Overall, the performed experiments did not 
suffer from any special effects. Neighbouring wells did not influence each other nor did the experiments suffer 
from border effects. This was all verified up front by preliminary test experiments and no correlations between 
Plate Average 
across 
plate
SD 
across 
plates
CV of 
Plate 
average10 9 8 7 6 5 4 3 2 1
Raw Signal NC-1 479 490 526 557 630 514 535 584 607 628
NC-2 504 511 517 573 593 559 581 548 583 656
NC-3 471 476 506 480 487 539 508 516 535 630
NC-4 524 506 614 593 628 554 548 628 548 701
Plate average 495 496 541 551 584 541 543 569 568 654 554 46 8%
Plate SD 24 16 49 49 67 20 30 48 33 34
Plate CV (%) 5% 3% 9% 9% 12% 4% 6% 8% 6% 5%
Table 2. Data from negative controls for experiment 10.
Plate
Average 
across 
plate
SD 
across 
plates CV
z’-factor 
using 
plate 
averages10 9 8 7 6 5 4 3 2 1
VAL 
165 nM-
Fix
Raw Signal
196 208 207 225 210 213 222 236 233 239
170 197 185 215 229 219 223 232 202 268
Plate average 183 202 196 220 219 216 223 234 217 253 216 20 9% 0.42
VAL 
7.2 µM 
-Fix
Raw Signal
151 176 176 188 193 187 184 248 184 188
144 171 168 186 175 179 184 255 184 214
Plate average 148 174 172 187 184 183 184 251 184 201 187 26 14% 0.41
CdCl2 
100 µM-
Fix
Raw Signal
162 167 159 174 158 147 157 156 152 164
163 148 154 165 158 136 142 140 164 163
155 163 151 180 178 122 170 174 147 163
Plate average 160 159 155 173 164 135 156 157 154 163 158 10 6% 0.58
Table 3. Data from Positive control for experiment 10.
8Scientific Data |            (2019) 6:46  | https://doi.org/10.1038/s41597-019-0053-2
www.nature.com/scientificdatawww.nature.com/scientificdata/
neighbouring items were observed. If effects were observed they always followed expected dose response relation-
ships i.e. low dose caused low response and high dose caused high response, often having a Hill or exponential shape.
comparison of results between and within experiments. In order to have a clear idea of the bio-
activity of the MNM in relation to different endpoints, the replicated measurements were analysed following 
the’signal-to-noise’ approach described above. The normalization allows the combination and comparison of the 
dose responses curves of different endpoints, different experiments, as well as different MNMs. Figure 5 shows 
an example of the induced effect on exposing HepaRG cells to different concentrations of AgPure (15 nm) for 
different features and for the 3 different experiments of the same type.
Combining the different experiments. Given the reproducibility of the three biological replicates, data 
were averaged across experiments for each of the items-concentration and endpoint. Following this approach 
Fig. 5 was summarized to Fig. 6, leading also to the data available in the final database.
Combining the data from different type of experiments and different batches. The raw data 
provides in total nine data sets for the tested items in Batch 1 (three for each type of experiment) and three data 
sets for Batch 2 and one for Batch 3.
The three types of experiments performed on Batch 1 all contain the Hoechst stain through which data is 
obtained for cell count, nuclear size, nuclear intensity. So for all 9 datasets those three endpoints can be used to 
analyse comparison. The same results in terms of the dose response curve shape and the point of departure were 
observed for all items, and therefore it was concluded that the data of different types of experiments of Batch 1 can 
be combined and complement each other. Although one could use the overall average of all 9 experiments for cell 
count, nuclear count and nuclear intensity, we opted to include within the database only the average of the three 
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Fig. 4 Behaviour of controls of the Mitochondrial Membrane Potential endpoint (experiment 10).
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obtained in the type 1 experiment in order to be consistent with the remaining part of the database. Nevertheless, 
all raw and transformed data are available in the Excel files.
Finally, a consistency check between the different batches was also performed. The results of all features for 
the present controls (positive control chemicals and reference MNM) were compared. All dose response curves 
showed high consistency of behaviour.
As a final result a database was constructed. It contains for each MNM one reliable dose response curve per 
endpoint obtained as an average of three independent experiments using the ‘signal-to-noise’ approach. The 
database is visualized in a heatmap27 where each row represents a MNM or relevant tested item and the columns 
contain the different endpoints for increasing concentrations. The colour code used goes from dark red identify-
ing a strong reduced ‘signal-to-noise’ to dark green for intermediate values moving then to dark blue identifying 
a strong increased ‘signal-to-noise’.
Materials are not grouped following a cluster analysis but according to their nano-form or relevance of 
nano-form. The upper part of the database includes the controls that were included in the various experiments. 
Besides MNMs in their pristine and aged form, the database also compares different coatings and sizes and, in 
some cases, also the supernatant is included to exclude specific effect of those.
code availability
Codes used for image processing and data acquisition for the three types of experiments have been made 
publically available and are included in the JRC data catalogue22.
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